Noradrenergic and cholinergic effects on speed and sensitivity measures of phasic alerting
Stephen B R E Brown1, Klodiana-Daphne Tona1, Martijn S van Noorden2
1Cognitive Psychology Unit.
Abstract:
An intense but task-irrelevant auditory accessory stimulus that is presented almost simultaneously with a visual imperative stimulus can reduce reaction times (RTs) to that stimulus. The information-processing locus and neural underpinnings underlying this phasic alerting effect are still poorly understood. The authors investigated a possible noradrenergic or cholinergic basis of the accessory stimulus effect in a double-blind pharmacological study (N = 18), in which healthy participants received a single dose of clonidine (an α2-adrenergic agonist), scopolamine (a muscarinic antagonist), and placebo in separate test sessions. A backward-masking procedure was used to examine, for the first time, the effect of accessory stimuli on perceptual sensitivity. The authors found that accessory stimuli enhanced perceptual sensitivity and decreased RTs to target stimuli, consistent with a recent hypothesis that phasic alerting speeds up stimulus encoding. In contrast to the authors' expectations, clonidine increased the accessory stimulus effect, a finding that seems at odds with earlier proposals that phasic alerting effects are mediated by a phasic noradrenergic response. Furthermore, the accessory stimulus effect was modulated to a similar extent by clonidine and scopolamine, suggesting that the effect of clonidine was not specific to the noradrenergic system. The results instead suggest that clonidine and scopolamine decrease general alertness and that these drug-related reductions in alertness yield room for compensatory performance improvements by phasic alerting.
More Related Videos
07:47The Rodent Psychomotor Vigilance Test rPVT: A Method for Assessing Neurobehavioral Performance in Rats and Mice
Published on: December 29, 2016
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Sympathetic Activation
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Drugs Affecting Neurotransmitter Release or Uptake
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
